Maravai LifeSciences (NASDAQ:MRVI – Free Report) had its price target trimmed by Morgan Stanley from $12.00 to $11.00 in a research note released on Thursday, Benzinga reports. The brokerage currently has an overweight rating on the stock. Several other equities research analysts have also issued reports on MRVI. The Goldman Sachs Group lowered their target […]
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) has been assigned an average recommendation of “Hold” from the nine analysts that are covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year target price […]
Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) have received an average rating of “Hold” from the nine brokerages that are presently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year price […]
Cannon Global Investment Management LLC bought a new stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 15,800 shares of the company’s stock, valued at approximately $196,000. Other large investors have also recently […]
Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $9.18 and last traded at $9.18, with a volume of 1295612 shares changing hands. The stock had previously closed at $9.60. Wall Street Analysts Forecast Growth MRVI […]